RightFit
RecruitingPhase not listed

Gastrointestinal Biomarkers in Tissue and Biological Fluid Samples From Colorectal Cancer Patients

Novel Colon Cancer Markers in Gastrointestinal Tissue and Biofluids

Who can join

As published by the study on ClinicalTrials.gov. "Not stated" means the study hasn't said — ask the study team.

Age
18 Years and older
Sex
All sexes
Healthy volunteers
Not accepted
Compensation
Not stated

Other requirements are listed under Eligibility below. Only the study team can confirm whether you can join.

What to expect

No one can promise a trial will help you personally — that is what the research is trying to find out.

What participation involves

  • Time periods mentioned: 5 years

Only what the study's summary and detailed description on ClinicalTrials.gov say. Time periods may describe the whole study or a part of it — ask the study team what applies to you.

Show the study's own words
  • "Patients are followed once a year for up to 5 years to determine if biomarkers have a prognostic significance."
Compensation
Not stated
  • Study-related exams and procedures are typically provided at no cost. This is how many trials work in general — confirm the details for this study with the study team.
  • Participants are monitored closely by the research team throughout the study.
  • Some participants may receive access to an investigational treatment, which is still being studied.
  • Your participation helps researchers learn whether this approach could help future patients.

About this study

In plain language

This study looks for biomarkers—signs in the body linked to cancer—in tissue, blood, urine, stool, and other body fluids. It is for people having tests of their digestive tract who have or have been treated for digestive tract cancer, polyps, or inflammatory bowel disease.

RATIONALE: Studying samples of tissue, blood, urine, stool, and other biological fluids from patients with cancer and from healthy volunteers undergoing colonoscopy or endoscopy may help doctors identify and learn more about biomarkers related to cancer. PURPOSE: This research study is looking at gastrointestinal biomarkers in tissue and biological fluid samples from patients and participants undergoing colonoscopy, endoscopy, or surgery.

Compensation is read from the study's own description and may be missing — always confirm with the study team.

Eligibility

Who can join

  • Having a colonoscopy or endoscopy to check for disease at Vanderbilt University Medical Center or the Veterans Affairs Medical Center. These tests use a scope to look inside the digestive tract.
  • Have or have been treated for digestive tract cancer, polyps (growths), or inflammatory bowel disease (long-term swelling in the bowel).
  • Able to understand the study and give consent to take part.

Who can't join

  • Have a mental or medical impairment.
  • Have a bleeding disorder.

Simplified for readability. The official criteria below are what the study team uses.

Official eligibility criteria

DISEASE CHARACTERISTICS: * Undergoing colonoscopy or endoscopy for diagnostic or screening purposes at the Vanderbilt University Medical Center or at the Veterans Affairs Medical Center AND * Meets 1 of the following criteria: * Diagnosis of gastrointestinal (GI) cancer, polyps, or inflammatory bowel disease * History of previously treated GI cancer, polyps, or inflammatory bowel disease PATIENT CHARACTERISTICS: * Capable of giving informed consent * Not mentally or medically impaired * No bleeding disorder PRIOR CONCURRENT THERAPY: * See Disease Characteristics

Study sites (2)

TN